Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
New medicines: human
Get the latest updates from New medicines: human directly as they happen.
Follow now 501 followers
Latest posts
Last updated 25 days ago
Human medicines European public assessment report (EPAR): Enflonsia, clesrovimab, Status: Opinion
25 days ago
Human medicines European public assessment report (EPAR): Enflonsia, clesrovimab, Status: Opinion
Human medicines European public assessment report (EPAR): Imaavy, nipocalimab, Status: Opinion
25 days ago
Human medicines European public assessment report (EPAR): Imaavy, nipocalimab, Status: Opinion
Human medicines European public assessment report (EPAR): Lynkuet, elinzanetant, Status: Opinion
25 days ago
Human medicines European public assessment report (EPAR): Lynkuet, elinzanetant, Status: Opinion
Human medicines European public assessment report (EPAR): Degevma, denosumab, Status: Opinion
25 days ago
Human medicines European public assessment report (EPAR): Degevma, denosumab, Status: Opinion
Human medicines European public assessment report (EPAR): Kefdensis, denosumab, Status: Opinion
25 days ago
Human medicines European public assessment report (EPAR): Kefdensis, denosumab, Status: Opinion
Human medicines European public assessment report (EPAR): Usgena, ustekinumab, Status: Opinion
25 days ago
Human medicines European public assessment report (EPAR): Usgena, ustekinumab, Status: Opinion
Human medicines European public assessment report (EPAR): Zvogra, denosumab, Status: Opinion
25 days ago
Human medicines European public assessment report (EPAR): Zvogra, denosumab, Status: Opinion
Human medicines European public assessment report (EPAR): Acvybra, denosumab, Status: Opinion
25 days ago
Human medicines European public assessment report (EPAR): Acvybra, denosumab, Status: Opinion
Human medicines European public assessment report (EPAR): Denosumab Intas, denosumab, Status: Opinion
25 days ago
Human medicines European public assessment report (EPAR): Denosumab Intas, denosumab, Status: Opinion
Human medicines European public assessment report (EPAR): Gobivaz, golimumab, Status: Opinion
25 days ago
Human medicines European public assessment report (EPAR): Gobivaz, golimumab, Status: Opinion
Human medicines European public assessment report (EPAR): Kyinsu, insulin icodec,semaglutide, Status: Opinion
25 days ago
Human medicines European public assessment report (EPAR): Kyinsu, insulin icodec,semaglutide, Status: Opinion
Human medicines European public assessment report (EPAR): Ponlimsi, denosumab, Status: Opinion
25 days ago
Human medicines European public assessment report (EPAR): Ponlimsi, denosumab, Status: Opinion